Development of therapy for regulation of liver cirrhosis by antisense gene and transplantation of proliferative hepatocyte
反义基因调控肝硬化疗法及增殖性肝细胞移植的研究进展
基本信息
- 批准号:09557100
- 负责人:
- 金额:$ 6.02万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Experiment 1 : For establishment of an animal model with liver cirrhosis, CCl4 and dimethyl nitrosoamine (DMNA) were administered to mouse and rat. Liver of animals with administration of CCl4 were cirrhotic but parenchymal hepatocyte was injured so severely. On the other hand, liver of rat with administration of DMNA was sever cirrhotic and hepatocyte seemed to be almost normal. Therefore, we conclude that rat with administration of DMNA was suitable for experiment of cirrhosis. Experiment 2 : In model with liver cirrhosis efficucies of HGF and antagonist of TGFb administration were examined after liver resection. HGF had an effect on progress of regeneration but antagonist of TGFb had no remarkable effect on regeneration and it counteracted the effect of HGF. Experiment 3 : For making hybridoma which has function of hepatocyte and proliferates, we tried to make cell fusion equipment using laser. Using this device, we could make hybridoma from mouse myeloma cells and lymphocytes. We made clone from this hybridoma and examined characters of both original cells. In addition we made hybridoma with myeloma cells and hepatocytes and are investigating the character of this hybridoma now. Experiment 4 : For treatment of cell function by gene transduction, we carried out the preliminary study that antisense for mRNA of TNF was encapsuled with HVJ liposome and was transfected to Kupffer cells. With antisense therapy, production of TNF decreased to 40%. Now using Ito cells, effect of antisense therapy is investigating. Gene therapy using antisense of mRNA of collagenase inhibitor is still not done yet.
实验一:用四氯化碳和二甲基亚硝胺(DMNA)分别对小鼠和大鼠建立肝硬变动物模型。经CCl_4染毒的大鼠肝脏有明显的肝硬变,但实质肝细胞损伤严重。DMNA组大鼠肝脏出现严重的肝硬变,肝细胞基本正常。因此,DMNA可作为大鼠实验性肝硬变的动物模型。实验2:观察肝切除术后肝细胞生长因子和肿瘤生长因子b拮抗剂对大鼠肝纤维化模型的影响。HGF对再生进程有一定影响,而TGFb拮抗剂对再生无明显影响,可抵消HGF的作用。实验三:为了制作具有肝细胞功能和增殖功能的杂交瘤,我们尝试用激光制作细胞融合装置。利用这个装置,我们可以用小鼠骨髓瘤细胞和淋巴细胞制作杂交瘤。我们从该杂交瘤细胞中克隆,并对两个原始细胞的特性进行了检测。此外,我们还用骨髓瘤细胞和肝细胞制作了杂交瘤,目前正在对杂交瘤的特性进行研究。实验四:为了通过基因转导治疗细胞功能,我们进行了反义肿瘤坏死因子基因的脂质体包裹并转导Kupffer细胞的初步研究。反义治疗后,肿瘤坏死因子的产量下降到40%。现在利用伊藤细胞,反义治疗的效果正在研究中。胶原酶抑制因子反义基因治疗仍未见报道。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHKOHCHI Nobuhiro其他文献
OHKOHCHI Nobuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHKOHCHI Nobuhiro', 18)}}的其他基金
Establishment of new treatment by thrombopoietin receptor agonist for liver regeneration in liver cirrhosis and for prevention of liver carcinogenes
血小板生成素受体激动剂治疗肝硬化肝再生和预防肝癌的新疗法的建立
- 批准号:
26293296 - 财政年份:2014
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New method of differential diagonosis and tailor- made treatmentfor hepatocellular carcinoma by antisense RNA
反义RNA肝细胞癌鉴别诊断及个体化治疗新方法
- 批准号:
23650611 - 财政年份:2011
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Translational research of developing liver regeneration and antie agent derived from platelets
开发肝再生和血小板源抗剂的转化研究
- 批准号:
20390350 - 财政年份:2008
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new treatment for severe liver diseases using platelets
开发利用血小板治疗严重肝病的新疗法
- 批准号:
17390359 - 财政年份:2005
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
MECHANISMS AND PREVENTION OF GRAFT INJURY OF THE LIVER GRAFT IN NON-HEART-BEATING DONOR.
无心跳供体肝移植损伤的机制和预防。
- 批准号:
11470253 - 财政年份:1999
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Gene therapy-for live cirrhosis by multiplicable hepatocyte and antisense of collagenase-mRNA
基因治疗-通过增殖性肝细胞和胶原酶-mRNA反义治疗活肝硬化
- 批准号:
07671353 - 财政年份:1995
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Senolytic trial for Aged Liver Regeneration Failure
老年肝脏再生失败的 Senolytic 试验
- 批准号:
23K19457 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
- 批准号:
10607301 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Promoting in vitro propagation of primary human hepatocytes as organoids using cues from natural liver regeneration
利用自然肝再生的线索促进原代人肝细胞作为类器官的体外增殖
- 批准号:
471981 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Fellowship Programs
A new role of pancreatic growth-related factors (REG3) in two-staged rapid liver regeneration
胰腺生长相关因子(REG3)在两阶段快速肝再生中的新作用
- 批准号:
22K08817 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
- 批准号:
10631156 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH
肝心磷脂水平的恢复和保存促进 AH 中的肝再生
- 批准号:
10708057 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
The cell identification research of bone marrow drived liver repaired cell in the new liver regeneration therapy
新型肝再生疗法中骨髓驱动的肝修复细胞的细胞鉴定研究
- 批准号:
22K08057 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
de novo approach to liver regeneration and liver disease focusing on PUFA containing phospholipids
以含有磷脂的 PUFA 为重点的肝再生和肝病从头方法
- 批准号:
22K08788 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Do Revival Stem Cells Contribute to Liver Regeneration?
复兴干细胞有助于肝脏再生吗?
- 批准号:
RGPIN-2020-07168 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Discovery Grants Program - Individual
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
- 批准号:
10501501 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别: